Market Overview:
The global extracorporeal membrane oxygenation device market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of respiratory diseases, technological advancements in ECMO devices, and rising demand for ECMO devices from emerging markets. Based on type, the global extracorporeal membrane oxygenation device market is segmented into veno artrial (VA), veno venous (VV), and artrio venous (AV) segments. The AV segment is expected to grow at the highest CAGR during the forecast period owing to its advantages over other types of ECMO devices such as lower risk of thrombosis and higher efficiency in terms of gas exchange. Based on application, the global extracorporeal membrane oxygenation device market is segmented into hospitals, clinics, and ambulatory surgical centers segments. The hospitals segment accounted for the largest share of this market in 2017 owing to increased use of ECMO devices for treatment purposes in hospitals across the world.
Product Definition:
An extracorporeal membrane oxygenation device (ECMO) is a piece of medical equipment that helps pump blood and oxygen to the body when the heart and lungs can't do it on their own.
Veno Artrial (VA):
Veno artrial (VA) is a method of delivering blood flow to organs or tissues that are not accessible to direct arterial pressure. It is used in Extracorporeal Membrane Oxygenation (ECMO) devices, which are used for the treatment of respiratory failure and other conditions where it is difficult to provide adequate oxygen supply through the mouth and nose.
Veno artrial disease has an incidence rate of 1 per 100,000 people annually in North America.
Veno Venous (VV):
Veno venous (VV) is a blood flow technique used to measure the rate and volume of blood flowing through the heart. It helps in monitoring cardiac function, which cannot be done with invasive methods. Veno venous pressure is used as an alternative to central venous pressure for evaluating right atrial appendage hypertension in patients undergoing catheterization procedures.
Application Insights:
Based on the application, the global ECMO device market is segmented into hospitals, clinics and ambulatory surgical centers. The hospitals segment dominated the overall market in terms of revenue in 2017 owing to a large patient base that requires ECMO therapy for various conditions. This can be attributed to a high prevalence of respiratory and cardiovascular diseases along with an increasing number of transplant surgeries across countries such as India, China and Brazil. In addition, factors such as rising healthcare spending by governments at both national and local levels coupled with technological advancements are expected to drive demand over the forecast period.
Regional Analysis:
Europe dominated the global market in 2017 owing to the presence of well-established healthcare infrastructure, high adoption rate of technologically advanced products, and increasing demand for minimally invasive surgeries. In addition, growing prevalence of chronic diseases such as stroke and heart failure is expected to drive the regional market over the forecast period. Asia Pacific is expected to witness lucrative growth during the forecast period due to rising geriatric population base coupled with increasing cardiovascular disease incidence rates in this region. Moreover, improving healthcare facilities and reimbursement policies are also contributing toward regional growth.
Major players operating in this industry include Fresenius Medical Care; Medtronic; B Braun Melsungen AG; Stryker; Terumo BCT Corporation.; Masimo Corporation.; HeartSine Inc.; Abbott Laboratories Inc.; Integra LifeSciences LLC.
Growth Factors:
- Increasing incidence of respiratory diseases: The increasing incidence of respiratory diseases is one of the major growth drivers for the extracorporeal membrane oxygenation device market. Respiratory diseases are caused due to various factors such as air pollution, smoking, and occupational hazards. According to the World Health Organization (WHO), around 3 million people die every year due to respiratory problems. This number is expected to increase in the coming years owing to the rising pollution levels across the globe. This will create a high demand for extracorporeal membrane oxygenation devices, which will boost the growth of this market during the forecast period.
- Technological advancements: The technological advancements in extracorporeal membrane oxygenation devices are another key factor driving their growth globally. These devices have become more sophisticated over time and can now be used for a variety of applications such as neonatal care, cardiac surgery, and liver failure treatment among others. This has led to an increase in their adoption by hospitals and other healthcare facilities worldwide, thereby propelling market growth during the forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Extracorporeal Membrane Oxygenation Device Market Research Report
By Type
Veno Artrial (VA), Veno Venous (VV), Artrio Venous
By Application
Hospitals, Clinics, Ambulatory Surgical Centers
By Companies
Maquet, Medtronics, Sorin, Terumo Medical, Nipro Medical, Medos Medizintechnik, MicroPort Scientific, Getinge, LivaNova, XENIOS, OriGen Biomedical, ALung Technologies, Eurosets
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Extracorporeal Membrane Oxygenation Device Market Report Segments:
The global Extracorporeal Membrane Oxygenation Device market is segmented on the basis of:
Types
Veno Artrial (VA), Veno Venous (VV), Artrio Venous
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Ambulatory Surgical Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Maquet
- Medtronics
- Sorin
- Terumo Medical
- Nipro Medical
- Medos Medizintechnik
- MicroPort Scientific
- Getinge
- LivaNova
- XENIOS
- OriGen Biomedical
- ALung Technologies
- Eurosets
Highlights of The Extracorporeal Membrane Oxygenation Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Veno Artrial (VA)
- Veno Venous (VV)
- Artrio Venous
- By Application:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Extracorporeal Membrane Oxygenation Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
An Extracorporeal Membrane Oxygenation Device (EMOD) is a medical device that uses an artificial membrane to remove oxygen from blood. The device is used to treat conditions such as anemia, heart failure, and stroke.
Some of the major players in the extracorporeal membrane oxygenation device market are Maquet, Medtronics, Sorin, Terumo Medical, Nipro Medical, Medos Medizintechnik, MicroPort Scientific, Getinge, LivaNova, XENIOS, OriGen Biomedical, ALung Technologies, Eurosets.
The extracorporeal membrane oxygenation device market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Extracorporeal Membrane Oxygenation Device Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Extracorporeal Membrane Oxygenation Device Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Extracorporeal Membrane Oxygenation Device Market - Supply Chain
4.5. Global Extracorporeal Membrane Oxygenation Device Market Forecast
4.5.1. Extracorporeal Membrane Oxygenation Device Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Extracorporeal Membrane Oxygenation Device Market Size (000 Units) and Y-o-Y Growth
4.5.3. Extracorporeal Membrane Oxygenation Device Market Absolute $ Opportunity
5. Global Extracorporeal Membrane Oxygenation Device Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Extracorporeal Membrane Oxygenation Device Market Size and Volume Forecast by Type
5.3.1. Veno Artrial (VA)
5.3.2. Veno Venous (VV)
5.3.3. Artrio Venous
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Extracorporeal Membrane Oxygenation Device Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Extracorporeal Membrane Oxygenation Device Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Ambulatory Surgical Centers
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Extracorporeal Membrane Oxygenation Device Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Extracorporeal Membrane Oxygenation Device Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Extracorporeal Membrane Oxygenation Device Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Extracorporeal Membrane Oxygenation Device Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Extracorporeal Membrane Oxygenation Device Demand Share Forecast, 2019-2026
9. North America Extracorporeal Membrane Oxygenation Device Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Extracorporeal Membrane Oxygenation Device Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Extracorporeal Membrane Oxygenation Device Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Ambulatory Surgical Centers
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Extracorporeal Membrane Oxygenation Device Market Size and Volume Forecast by Type
9.7.1. Veno Artrial (VA)
9.7.2. Veno Venous (VV)
9.7.3. Artrio Venous
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Extracorporeal Membrane Oxygenation Device Demand Share Forecast, 2019-2026
10. Latin America Extracorporeal Membrane Oxygenation Device Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Extracorporeal Membrane Oxygenation Device Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Extracorporeal Membrane Oxygenation Device Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Ambulatory Surgical Centers
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Extracorporeal Membrane Oxygenation Device Market Size and Volume Forecast by Type
10.7.1. Veno Artrial (VA)
10.7.2. Veno Venous (VV)
10.7.3. Artrio Venous
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Extracorporeal Membrane Oxygenation Device Demand Share Forecast, 2019-2026
11. Europe Extracorporeal Membrane Oxygenation Device Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Extracorporeal Membrane Oxygenation Device Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Extracorporeal Membrane Oxygenation Device Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Ambulatory Surgical Centers
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Extracorporeal Membrane Oxygenation Device Market Size and Volume Forecast by Type
11.7.1. Veno Artrial (VA)
11.7.2. Veno Venous (VV)
11.7.3. Artrio Venous
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Extracorporeal Membrane Oxygenation Device Demand Share, 2019-2026
12. Asia Pacific Extracorporeal Membrane Oxygenation Device Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Extracorporeal Membrane Oxygenation Device Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Extracorporeal Membrane Oxygenation Device Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Ambulatory Surgical Centers
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Extracorporeal Membrane Oxygenation Device Market Size and Volume Forecast by Type
12.7.1. Veno Artrial (VA)
12.7.2. Veno Venous (VV)
12.7.3. Artrio Venous
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Extracorporeal Membrane Oxygenation Device Demand Share, 2019-2026
13. Middle East & Africa Extracorporeal Membrane Oxygenation Device Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Extracorporeal Membrane Oxygenation Device Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Extracorporeal Membrane Oxygenation Device Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Ambulatory Surgical Centers
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Extracorporeal Membrane Oxygenation Device Market Size and Volume Forecast by Type
13.7.1. Veno Artrial (VA)
13.7.2. Veno Venous (VV)
13.7.3. Artrio Venous
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Extracorporeal Membrane Oxygenation Device Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Extracorporeal Membrane Oxygenation Device Market: Market Share Analysis
14.2. Extracorporeal Membrane Oxygenation Device Distributors and Customers
14.3. Extracorporeal Membrane Oxygenation Device Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Maquet
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Medtronics
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Sorin
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Terumo Medical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Nipro Medical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Medos Medizintechnik
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. MicroPort Scientific
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Getinge
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. LivaNova
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. XENIOS
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. OriGen Biomedical
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. ALung Technologies
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Eurosets
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
